ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Cash from investing

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥12.69T
P/E ratio
27.5x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Dec 31, 2025-201,273-11.48%
Dec 31, 2024-227,365+509.72%
Dec 31, 2023-37,290-74.46%
Dec 31, 2022-145,994+22.76%
Dec 31, 2021-118,927+20.97%
Dec 31, 2020-98,312+20.27%
Dec 31, 2019-81,741+10.37%
Dec 31, 2018-74,060+101.70%
Dec 31, 2017-36,718+263.29%
Dec 31, 2016-10,107-77.67%
Dec 31, 2015-45,269+215.44%
Dec 31, 2014-14,351+8.61%
Dec 31, 2013-13,213-75.93%
Dec 31, 2012-54,901

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat